| Presented by: | The American College of Chest Physicians |
| Lecturer | Albert J. Polito, MD, FCCP |
| Approximate duration: | Not available |
| Summary points: | This text-based educational program describes the basic structure and mode of action of three antitumour necrosis factor (TNF) alpha agents, clinical manifestations of tuberculosis in the setting of anti-TNF-alpha therapy, prevention and treatment, clinical presentations of specific fungal and bacterial infections, the spectrum of noninfectious pulmonary complications of anti-TNF-alpha therapy, as well as the advantages and limitations of the Adverse Event Reporting System of the US Food and Drug Administration in monitoring adverse drug events in the postmarketing setting. |
| Accreditation: | The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Chest Physicians designates this educational activity for a maximum of 24.0 AMA PRA Category 1 Credit(s).
Expiration date: December 31, 2010. |
| Other: | Text-only CME. |
E-Mail this webcast/CME to a colleague
Pulmonary Complications of Anti-Tumor Necrosis Factor-a Therapy
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
